We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 114,164 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/2/2021 13:40 | I think folks had anticipated this news Raf so not a ‘surprise̵ | semper vigilans | |
17/2/2021 13:35 | I am surprised there is not more buying on the news today, can’t please everyone I suppose. | rafboy | |
17/2/2021 13:31 | You will not be able to get any of this stock in the near future. As anticipation ramps towards the end of the trial and any other news at all from the other sectors will put the price right up there. | madaboutmed | |
17/2/2021 13:29 | And that is Socio filtered now along with Kreature and the many variation of Senti. | madaboutmed | |
17/2/2021 11:49 | RNS out - Trial started, what a great surprise today, unexpected at this time of the day but very welcomed. Expect a lot more articles from lemming investor and TW to reiterate the start of the trial, what an amazing benchmark. I believe 40p will be the floor now and 50p the next short term target. | allseeingeye1 | |
17/2/2021 11:48 | Good job hitting deadlines and updating the market in a timely fashion. I like the way the company goes about its business. | blah blah | |
17/2/2021 11:47 | Nice to see the expanded trial commence, should be an interesting few months ahead. | rafboy | |
17/2/2021 11:40 | Well said. I think it is time for us all to filter him. | madaboutmed | |
17/2/2021 11:20 | Gee thanks socionomics. When it doesn't hit 28-29p in the next two to three weeks, let's be generous and say by 12 March, will you kindly bore off somewhere else? Just the fact that you call your prediction 'a fact' should be enough to disbar you from any serious conversation. | blah blah | |
17/2/2021 10:12 | Socio, you have no evidence to point your ridiculous claim up and are only wanting to get a cheaper entry. Your low life antics will not work. If you want to get in now is the time as we are still low enough for you to at least triple your investment. 28p will not be seen here again so keep watching and I will keep smiling knowing you will never get your entry price. Trial should be starting any day now | allseeingeye1 | |
17/2/2021 10:04 | You clearly have not done any research at all on this company. The management team have a flawless record of delivering what they say on time. The forthcoming trial alone has the ability to triple the share price from where we are today once it has commercialised. Add the activity in other sectors and the new IP they are pursuing and you derisk all day long. This is not a one trick pony. | madaboutmed | |
17/2/2021 08:43 | Agreed, my fellow investor. | christopher logsdon | |
17/2/2021 08:32 | Morning Chaps, I think it’s great that we don’t (yet) have here the rampy type posts that we are getting from one or two posters on the Opti BB At the moment this BB is not dominated by what looks like a few traders over there trying to talk the price up It seems to me that currently most here are solid holders quietly waiting for company transforming news that could drop at any time | judijudi | |
17/2/2021 00:12 | This fits with the point I was making. The down days were thin volume, then reverse on the next trading day on larger volume. This points to weak traders banking profits and accumulators taking advantage. Also, crude analysis. 🤣 | elrico | |
16/2/2021 23:12 | I'm not convinced about the merits of TA when applied to thinly traded, little analysed shares. The Tescos of this world yes but not the minnows where news often brings dramatic price movements. One thing I will often look at however is on-balance volume, it can reveal a lot when the price is going sideways. SBTX reached the present price about 25/1. Three weeks since between 35p and 42p, yet during that time the OBV has steadily and strongly increased. Crudely put, this indicates that the up days enjoyed greater volume than the down days. Often a sign that a move up is coming. Not certain of course but perhaps a straw in the wind. | alanrussell | |
16/2/2021 22:31 | Socio, Try asking yourself why there is heavy buying pressure each time the share price falls to 35/37p level? It doesn't show on the above charts, but it is there. If you go back a few weeks, you may recall SA stating he is in late-stage discussions with 6 potential partners for CleanBiotix. Any one of these could land at any time. What do you think would happen? I'd wager an even higher floor, and of course, the probiotic study will generate a lot of excitement. I know wealth is building positions between 35p and 40p, so unless they change their strategy, you have little to zero chance of seeing 28p again. By all means, trade around the edges if gaining a few pence if it is important to you, but you risk being caught out. Quite a few LTH bailed between 28p and 32p and regretted doing so. They sit on the sidelines, praying you are correct; otherwise, they will need to buy back higher and have fewer shares for their troubles. Please, less of the deception, we have seen your antic many times. | elrico | |
16/2/2021 17:55 | >> socio Very strange call. We have a flagpole and pennant forming which is very bullish. It may take a little longer to play out but then we are off to the races! | nobbygnome | |
16/2/2021 15:03 | What a load of nonsense. | madaboutmed |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions